• News

    HDA’s President and CEO Chester “Chip” Davis, Jr., Testifies Before House Energy and Commerce Health Subcommittee on Generic Drug Shortages

    September 14, 2023

    Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., testified before the House Energy and Commerce Subcommittee on Health during a legislative hearing on proposals to prevent and respond to generic drug shortages.

  • News

    Kaminsky and Hatcher To Lead HDA Board of Directors; Syvinski Appointed to Executive Committee

    September 12, 2023

    The Healthcare Distribution Alliance (HDA) announced Kirk Kaminsky and Jody Hatcher will serve a second year as Chairman and Vice Chairman, respectively, of the HDA Board of Directors.

  • News

    HDA Appoints Kala Shankle Vice President of Regulatory Affairs

    September 05, 2023

    HDA announces the appointment of Kala Shankle as Vice President of Regulatory Affairs.

  • News

    HDA Statement on FDA Enforcement Discretion for the DSCSA’s Final Implementation Requirements

    August 25, 2023

    The Healthcare Distribution Alliance (HDA) released a statement from President and CEO Chester “Chip” Davis, Jr., on the Food and Drug Administration’s (FDA) announcement that it plans to exercise enforcement discretion for the Drug Supply Chain Security Act’s (DSCSA) final implementation requirements.

  • News

    HDA To Host Traceability Seminar in August

    July 11, 2023

    The Healthcare Distribution Alliance (HDA) will host its annual Traceability Seminar two months early, on August 29–31, 2023, in Washington, D.C. The earlier date reflects the urgency surrounding the upcoming Drug Supply Chain Security Act (DSCSA) implementation deadline and the critical need to share information and solutions.

  • News

    HDA Recommends a Phased Approach to Implementing the Final Requirements of the DSCSA

    June 20, 2023

    The Healthcare Distribution Alliance (HDA) is recommending to the Food and Drug Administration (FDA) a phased approach to final implementation of the Drug Supply Chain Security Act (DSCSA) to minimize the potential for supply disruptions and interruptions to patient care. The proposal was communicated through a recent letter to FDA.

Media Contacts

John Parker
Senior Vice President, Communications and Marketing

Farah Simonett
Vice President, Communications and Marketing

Elizabeth Baker
Director, Communications